Indexed In
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- China National Knowledge Infrastructure (CNKI)
- Ulrich's Periodicals Directory
- RefSeek
- Hamdard University
- EBSCO A-Z
- Directory of Abstract Indexing for Journals
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 33, which means every article in Journal of Stem Cell Research & Therapy has got 33 average citations.
Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
22 | 58 | 59 | 65 | 23 | 13 | 36 | 34 | 49 | 63 | 101 | 62 | 44 | 26 |
Research, Review articles and Editorials |
2 | 4 | 1 | 2 | 12 | 12 | 29 | 28 | 44 | 56 | 80 | 48 | 12 | 19 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 54 | 58 | 63 | 11 | 1 | 7 | 6 | 5 | 7 | 21 | 14 | 32 | 6 |
Conference proceedings |
0 | 40 | 12 | 37 | 0 | 0 | 145 | 138 | 95 | 63 | 154 | 72 | 54 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
522 | 678 | 761 | 838 | 697 | 626 | 613 | 599 | 538 | 478 | 262 | 142 | 31 | 69 |
| Journal total citations count | 6793 |
| Journal impact factor | 1.64 |
| Journal 5 years impact factor | 1.70 |
| Journal cite score | 11.56 |
| Journal h-index | 33 |
Important citations
Alcohol and Cancer Stem Cells
Alcohol and Cancer Stem Cells
In Vivo Outcome of Homology-Directed Repair at the HBB Gene in HSC Using Alternative Donor Template Delivery Methods
Impact of perioperative pain management on cancer recurrence: an ASRA/ESRA special article
The role of TRIM family proteins in the regulation of cancer stem cell self-renewal
The role of TRIM family proteins in the regulation of cancer stem cell self-renewal
Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein
Editing the sickle cell disease mutation in human hematopoietic stem cells: comparison of endonucleases and homologous donor templates
Hypoxia Induces the Acquisition of Cancer Stem-like Phenotype Via Upregulation and Activation of Signal Transducer and Activator of Transcription-3 (STAT3) in MDA-MB-231, a Triple Negative Breast Cancer Cell Line
Increased Cellular Levels of MicroRNA-9 and MicroRNA-221 Correlate with Cancer Stemness and Predict Poor Outcome in Human Breast Cancer
Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
Editing a ?-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype
Lentiviral and genome-editing strategies for the treatment of ?-hemoglobinopathies
The delivery challenge: fulfilling the promise of therapeutic genome editing
Priming human repopulating hematopoietic stem and progenitor cells for Cas9/sgRNA gene targeting
Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives
Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing
Disruption of the BCL11A erythroid enhancer reactivates fetal hemoglobin in erythroid cells of patients with ?-thalassemia major
Cyclosporine H overcomes innate immune restrictions to improve lentiviral transduction and gene editing in human hematopoietic stem cells
Tregopathies: monogenic diseases resulting in regulatory T-cell deficiency